pharmaceutical

iX Biopharma secures Australia's GMP licence for its testing laboratory - THE EDGE SINGAPORE

Company in the news

iX Biopharma secures Australia's GMP licence for its testing laboratory

Shares in iX Biopharma closed flat at 24 cents on September 25.

Singapore economy

Singapore Sept factory output falls 0.2% y-o-y, misses forecasts

SINGAPORE (Oct 26): Singapore's industrial production unexpectedly fell in September from the year earlier as manufacturing in the electronics and pharmaceutical sectors took a dip, data showed on Friday.

IPO

Hyphens Pharma's public offering 152 times subscribed

SINGAPORE (May 17): Hyphens Pharma International says its public offering of 3 million shares at 26 cents per share in conjunction with its Catalist listing was about 152 times subscribed.

IPO

Hyphens Pharma lodges preliminary offer document for Catalist listing

SINGAPORE (Apr 26): Hyphens Pharma International, the specialty pharmaceutical and consumer healthcare group which also owns the Ocean Health brand of supplements, has lodged a preliminary offer document with Singapore Exchange (SGX) to list on its Catali

Acromec awarded two contracts totaling to $6.6 mil

SINGAPORE (Dec 22): Acromec, the specialist engineering service provider in the field of controlled environments, has secured two high-specification contracts worth $6.6 million in total.  
×